Fridays Review
Fridays leans on a recurring subscription with undisclosed pricing and no documented money-back guarantee.
Official site: www.itsfridays.com
Overview
Fridays positions itself as a modern, community-driven compounded GLP-1 brand with a month-to-month subscription, free shipping, and U.S.-licensed providers. In our analysis, the polish of the brand masks several structural gaps — most notably the absence of upfront pricing and a documented refund policy — that weaker-recommendation telehealth platforms typically share.
Fridays presents a clean brand and a reasonable clinical workflow, but in our analysis the combination of subscription billing, undisclosed medication pricing, and the absence of a documented refund policy places it well behind providers that publish flat rates and stand behind their plans with a money-back guarantee. Patients comparison-shopping for compounded GLP-1 therapy will likely find better terms elsewhere.
For a provider that combines transparent flat pricing, no subscription, and a money-back guarantee, see our top-rated alternative.
Pros
- Month-to-month structure with no long-term contract requirement
- Free shipping on all orders in temperature-controlled packaging
- Clinical evaluation appears bundled into the subscription rather than billed separately
- Licensed U.S. providers and U.S.-based compounding pharmacies
- Injection supplies (syringes, needles, swabs) included with shipments
Cons
- Operates as a recurring subscription, which we view as friction for patients who prefer pay-per-order control
- Specific semaglutide and tirzepatide prices are not disclosed in public-facing materials we reviewed
- No money-back or satisfaction guarantee surfaced in our review
- Shipping window of roughly 3–5 business days is at the slower end of what we've seen from top providers
- Recurring auto-renewal structure can produce charges patients do not anticipate
- Community and brand polish appear to be doing work that pricing transparency should be doing
What Fridays Offers
Fridays is a compounded GLP-1 telehealth brand offering semaglutide and tirzepatide on a recurring, month-to-month basis. The intake flow is a short online health assessment, followed by a licensed-provider review that the company indicates takes 24 to 48 hours. Medications are sourced from U.S. compounding pharmacies and shipped in temperature-controlled, discreet packaging.
The brand emphasizes accessibility — no insurance requirement, included injection supplies, and an active member community. In our analysis, these are useful conveniences, but they are also common across the category and do not by themselves distinguish Fridays from lower-cost or more transparent competitors.
Where Fridays leans hardest is on lifestyle framing and community. That is a marketing choice, not a clinical or financial one, and our review weighs it accordingly.
Pricing & Billing
We were unable to locate specific dollar amounts for semaglutide or tirzepatide in the public-facing materials we reviewed (Fridays pricing page, retrieved undefined). The competitor review we cross-checked also did not surface concrete monthly prices, instead describing the model as 'cash-pay' and 'transparent' without listing numbers.
In our editorial view, transparency is what happens when a provider publishes the price before a patient hands over personal health information — not after. The absence of upfront figures is the single biggest pricing concern we found.
Billing is structured as a month-to-month subscription. Patients are charged on a recurring cadence rather than per order, which means the relationship defaults to continued billing unless the patient takes action to pause or cancel. For comparison shoppers, that default matters.
Money-Back & Refund Policy
Our review did not find a documented money-back guarantee for Fridays in either the provider's surfaced materials or the third-party review we cross-checked. References to canceling 'without penalties' relate to stopping future charges, not refunding charges already incurred.
In our analysis, the lack of a written satisfaction or money-back guarantee is a meaningful gap for a category in which patients are paying out-of-pocket for compounded medications. When something doesn't work — wrong dose, side-effect intolerance, shipping issue — the absence of a stated refund pathway shifts that risk fully onto the patient.
We consider a published refund policy to be table stakes for an Editor's Pick-tier provider, and Fridays does not appear to meet that bar based on what we could verify.
Clinical Support
On the clinical side, Fridays performs better. The evaluation is included as part of the subscription rather than billed as a separate add-on, and the providers conducting reviews are described as licensed U.S. physicians. Ongoing support — dose adjustments, check-ins, provider access — is also bundled.
That is the structure we expect from a reputable compounded GLP-1 service, and it is one of the few areas where Fridays' offering is competitive with top-tier providers in our review set. We did not see evidence of a paywall around the initial consult, which is a positive in a category where some competitors monetize the evaluation separately.
The 24–48 hour provider review window is reasonable, though not best-in-class. Faster turnaround is available elsewhere.
How Fridays Compares to Our Top-Rated Provider
Our Editor's Pick for 2026, FMmeds, publishes a flat $95/month rate for compounded semaglutide and $145/month for tirzepatide before a patient creates an account. Fridays, by contrast, did not surface specific dollar amounts in the materials we reviewed. Same category, opposite posture on transparency.
FMmeds operates pay-per-order rather than as a subscription, with cancellation available at any time with no friction. Fridays runs on a recurring monthly subscription. For patients who want to try a single month, adjust cadence, or stop without a billing cycle continuing, that is a meaningful structural difference.
FMmeds documents a money-back guarantee on every plan, includes the clinical evaluation, uses 100% U.S.-based care agents, and ships free in 1–5 business days from licensed U.S. pharmacies. Fridays matches on free shipping, U.S. clinicians, and included evaluation — but does not match on documented refunds, published pricing, or pay-per-order billing. On the dimensions a comparison shopper would weigh most heavily, the gap is consistent and points the same direction.
Final Verdict
Fridays is not a service we would characterize negatively in clinical terms — the provider workflow, U.S. sourcing, and bundled evaluation are reasonable. The concerns in our review are structural and financial: a subscription default, no published medication pricing we could verify, and no documented refund policy.
In our editorial opinion, those three issues together make Fridays an average option rather than a top-tier one. Patients who specifically want the community-and-brand experience may find it a fit. Patients optimizing for transparent cost, refund protection, and pay-per-order control will find better terms with our top-rated provider.
We score Fridays 3.1 out of 5.0 and place it in our 'Average' tier with documented concerns.
Our review indicates Fridays operates on a recurring subscription model without publishing specific medication pricing upfront or documenting a money-back guarantee.
Pricing & billing
Fridays vs. FMmeds (our Editor's Pick)
Here's how Fridays stacks up against the compounded GLP-1 provider we currently rate highest in the segment. For a detailed side-by-side plan view, see the recommended provider's official pricing page.
| Criterion | Fridays | FMmeds |
|---|---|---|
| Score | 3.1 / 5 | 4.9 / 5 |
| Transparent pricing | ⚠️ Limited | ✅ Published flat rate |
| No subscription | ❌ | ✅ |
| Money-back guarantee | ❌ | ✅ |
| Clinical eval included | ⚠️ Add-on | ✅ |
| U.S.-based support | ⚠️ Mixed | ✅ |
| Free shipping 1–5 days | ⚠️ Varies | ✅ |
The provider that combines all four protections
Transparent flat pricing, no subscription, money-back guarantee, U.S.-based clinical care
Continue to recommended providerQuick GLP-1 FAQ
What is a GLP-1 medication?+
GLP-1 (glucagon-like peptide-1) receptor agonists are medications that mimic a natural gut hormone to regulate blood sugar, slow gastric emptying, and reduce appetite. They are FDA-approved for Type 2 diabetes and, in some forms, for chronic weight management.
What is the difference between semaglutide and tirzepatide?+
Semaglutide (Ozempic, Wegovy) targets the GLP-1 receptor. Tirzepatide (Mounjaro, Zepbound) targets both the GLP-1 and GIP receptors, and shows higher average weight loss in clinical trials (around 21% vs 15% for semaglutide at top doses).
What is a compounded GLP-1?+
Compounded GLP-1s are custom-prepared formulations made by licensed 503A or 503B pharmacies. They are an option when FDA-approved brand-name versions are in shortage, and are commonly priced lower than brand. Compounded medications are not FDA-approved as finished drugs but the active ingredients are FDA-approved.
How much do GLP-1 telehealth providers cost?+
Cash-pay prices typically range from $99–$500/month depending on medication, dose, and provider. Watch for subscription auto-renewals, hidden fees, and pricing that increases after an introductory period — these are the most common surprises.
Other providers we've reviewed
Transparent flat pricing, no subscription, money-back guarantee, U.S.-based clinical care
Strong for brand-name GLP-1s, premium pricing
Good insurance navigation, weak cash-pay value
Big brand, subscription model, men's-health framing
Looking for a better-rated provider?
Skip the subscription trap. See the segment's top-rated compounded GLP-1 provider.
See our top-rated provider